Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy
Mishra, V.; Daniel, R.C.; Elmets, C.A.; Levin, A.; Elewski, B.E.
Journal of Drugs in Dermatology Jdd 12(1): 16-17
2013
ISSN/ISBN: 1545-9616 PMID: 23377322 Document Number: 13935
Document emailed within 1 workday

Related Documents
Ghate, J.V.; Alspaugh, C.D. 2009: Adalimumab in the management of palmoplantar psoriasis Dermatology Online Journal 15(7): 15Laczkowska, M.; Zaba, R.; Bowszyc, J.; Borczyńska, M. 1987: The role of Chlamydia trachomatis in etiopathogenesis of localised psoriasis pustulosa and palmoplantar pustulosis Dermatologische Monatschrift 173(11): 670-673
Danesh, M.J.; Beroukhim, K.; Nguyen, C.; Levin, E.; Koo, J. 2015: Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasis Dermatology Online Journal 21(6)
Bissonnette, R.; Poulin, Y.; Bolduc, C.; Maari, C.; Provost, N.; Syrotuik, J.; Poulin-Costello, C.M.; Nigen, S. 2008: Etanercept in the treatment of palmoplantar pustulosis Journal of Drugs in Dermatology: Jdd 7(10): 940-946
Murray, D.; Warin, A.P. 1979: Photochemotherapy for persistent palmoplantar pustulosis (PPP) British Journal of Dermatology 101(Suppl 17): 13-14
Matsumoto, Y.; Kawahara, S.; Mizuno, N. 1987: A case of Sjogren's syndrome associated with palmoplantar pustulosis Ryumachi 27(4): 288-293
Le Goff, P.; Guillet, G.; Brousse, A.; Massé, R. 1984: Peristernal inflammatory rheumatism in palmoplantar pustulosis Annales de Dermatologie et de Venereologie 111(8): 719-720
Prier, A.; Koeger, A.C.; Di Crescenzo, M.C.; Canesi, M.F.; Camus, J.P. 1985: Vertebral and thoracic osteoarticular manifestations in palmoplantar pustulosis Annales de Medecine Interne 136(8): 615-619
Misiak-Galazka, M.; Wolska, H.; Galazka, A.; Kwiek, B.ło.; Rudnicka, L. 2018: General Characteristics and Comorbidities in Patients with Palmoplantar Pustulosis Acta Dermatovenerologica Croatica: Adc 26(2): 109-118
Le Goff, P.; Brousse, A.; Fauquert, P.; Guillet, G.; Leroy, J.P. 1985: Anterior thoracic and intervertebral erosive joint diseases associated with palmoplantar pustulosis Revue du Rhumatisme et des Maladies Osteo-Articulaires 52(6): 391-396
Huaux, J.P.; Malghem, J.; Rombouts, J.J.; Esselinckx, W.; Lokietek, J.C.; Noel, H.; Nagant de Deuxchaisnes, C. 1987: Chronic recurrent multifocal osteomyelitis in children and palmoplantar pustulosis. Apropos of a new case Revue du Rhumatisme et des Maladies Osteo-Articulaires 54(5): 403-405
Van de Kerkhof, P.C.; Chang, A.; van Dooren-Greebe, R.; Geiger, J.M.; Happle, R. 1988: Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin Acta Dermato-Venereologica 68(6): 499-503
Gupta, R.; Wu, J.J.; Levin, E.; Koo, J.Y.M.; Liao, W. 2013: Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient Journal of Drugs in Dermatology: Jdd 12(10): 1089
Rathod, D.; Weinberg, J.M..; Yamauchi, P.S..; Kircik, L.H..; Wollina, U.; Lotti, T.; Goldust, M. 2019: Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report Journal of Drugs in Dermatology: Jdd 18(4): 394-396
Remitz, A.; Lauerma, A.I.; Erkko, P.; Reitamo, S. 1996: Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens Acta Dermato-Venereologica 76(4): 310-313
Weinberg, J.M.; Bottino, C.J.; Lindholm, J.; Buchholz, R. 2005: Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept Journal of Drugs in Dermatology: Jdd 4(5): 544-555
Shiohara, T.; Kobayashi, M.; Ishii, Y.; Nagashima, M. 1987: Production of interleukin-2 and interleukin-2 inhibitor in patients with palmoplantar pustulosis Acta Dermato-Venereologica 67(5): 422-426
Witty, L.A.; Steiner, F.; Curfman, M.; Webb, D.; Wheat, L.J. 1992: Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis Archives of Dermatology 128(1): 91-93
Rocamora, V.ç; Garcías-Ladaria, J. 2017: Complete response of secukinumab in palmoplantar psoriasis Dermatology Online Journal 23(10)
Weinberg, J.M. 2003: Successful treatment of recalcitrant palmoplantar psoriasis with etanercept Cutis 72(5): 396-398